Loss of ADAMTS19 causes progressive non-syndromic heart valve disease. (Wünnemann F, Ta-Shma A, Preuss C, Leclerc S, van Vliet PP, Oneglia A, Thibeault M, Nordquist E, Lincoln J, Scharfenberg F, Becker-Pauly C, Hofmann P, Hoff K, Audain E, Kramer HH, Makalowski W, Nir A, Gerety SS, Hurles M, Comes J, Fournier A, Osinska H, Robins J, Pucéat M, MIBAVA Leducq Consortium principal investigators, Elpeleg O, Hitz MP, Andelfinger G) Nat Genet 2020 01;52(1):40-47 PMID: 31844321 PMCID: PMC7197892 SCOPUS ID: 2-s2.0-85076909295 12/18/2019 10 Citations
FGF23 induces left ventricular hypertrophy. (Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-O M, Kusek JW, Keane MG, Wolf M) J Clin Invest 2011 Nov;121(11):4393-408 PMID: 21985788 PMCID: PMC3204831 SCOPUS ID: 2-s2.0-80555148939 10/12/2011 1193 Citations